Cancer Therapeutics CRC Pty Ltd

Bundoora, Australia

Cancer Therapeutics CRC Pty Ltd

Bundoora, Australia
SEARCH FILTERS
Time filter
Source Type

Patent
Cancer Therapeutics CRC PTY LTD. | Date: 2015-02-11

A compound of the formula (I): where R^(1 )or R^(2 )is a cyclic amine group and R^(5 )is an aromatic group with a carbonyl containing substituent for use as a FAK inhibitor.


Patent
Cancer Therapeutics CRC Pty Ltd | Date: 2012-07-06

A compound of the formula (I): where R^(1 )or R^(2 )is a cyclc amine group and R^(5 )is an aromatic group with a carbonyl containing substituent for use as a FAK inhibitor.


Patent
Cancer Therapeutics CRC Pty Ltd | Date: 2012-07-06

A compound of the formula (I): where R^(1 )or R^(2 )is a cyclc amine group and R^(5 )is an aromatic group with a carbonyl containing substituent for use as a FAK inhibitor.


Patent
CANCER THERAPEUTICS CRC PTY Ltd | Date: 2013-08-16

This invention relates to compounds of the formula (I). The invention also relates to processes for the preparation of the compound of the formula (I), pharmaceutical agents or compositions containing the compound or a method of using the compound for the treatment of proliferative diseases, such as cancer as well as the treatment of diseases ameliorated by the control and/or inhibition of lymphanglogenesis.


Patent
CANCER THERAPEUTICS CRC PTY Ltd | Date: 2013-08-16

This invention relates to compounds of the formula (I): The invention also relates to processes for the preparation of the compound of the formula (I), pharmaceutical agents or compositions containing the compound or a method of using the compound for the treatment of proliferative diseases, such as cancer, as well as the treatment of diseases ameliorated by the control and/or inhibition of lymphangiogenesis.


Patent
Cancer Therapeutics CRC Pty Ltd | Date: 2012-02-17

A compound of the formula (I): where R^(1 )or R^(2 )is a cyclc amine group and R^(5 )is an aromatic group with a carbonyl containing substituent for use as a FAK inhibitor.


Patent
Cancer Therapeutics CRC Pty Ltd | Date: 2012-02-17

A compound of the formula (I): where R^(1 )or R^(2 )is a cycle, amine group and R^(5 )is an aromatic group with a carbonyl containing substituent for use as a FAK inhibitor.


Substituted benzimidazole and 3H-imidazo[4,5-b]pyridines or formula I: where X and Y respectively are selected from: (i) N and N; and (ii) N and CR^(4); A^(2 )is selected from: a C_(5 )heteroarylene group, containing 2 or 3 ring heteroatoms, where the bonds to L1 and the core are to one another; L^(1 )is selected from: (i) ^(A1)OCH_(2)^(A2); (ii) ^(A1)CH_(2)O^(A2); (iii) ^(A1)C(O)NH^(A2); (iv) ^(A1)CH(OH)^(A2); (v) ^(A1)CH_(2)NHC(O)^(A2); (vi) ^(A1)SCH_(2)^(A2); (vii) ^(A1)CH_(2)S^(A2); (viii) ^(A1)CH_(2)^(A2); and (ix) ^(A1)CH(CH_(3))O-^(A2); A1 is phenyl, optionally substituted by F or CF_(3); their use as pharmaceuticals, and in particular, in treating cancer and hemoglobinopathies.


Patent
CANCER THERAPEUTICS CRC PTY Ltd | Date: 2013-08-16

This invention relates to a compound of the formula (I): The invention also relates to processes for the preparation of the compound of the formula (I), pharmaceutical agents or compositions containing the compound or a method of using the compound for the treatment of proliferative diseases, such as cancer, as well as the treatment of diseases ameliorated by the control and/or inhibition of lymphangiogenesis.


Patent
CANCER THERAPEUTICS CRC PTY Ltd | Date: 2013-08-16

This invention relates to a compound of the formula (I): The invention also relates to processes for the preparation of the compound of the formula (I), pharmaceutical agents or compositions containing the compound or a method of using the compound for the treatment of proliferative diseases, such as cancer, as well as the treatment of diseases ameliorated by the control and/or inhibition of lymphangiogenesis.

Loading Cancer Therapeutics CRC Pty Ltd collaborators
Loading Cancer Therapeutics CRC Pty Ltd collaborators